GE HealthCare Technologies Inc. $GEHC Shares Sold by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 83,381 shares of the company’s stock after selling 87,502 shares during the period. Swiss Life Asset Management Ltd’s holdings in GE HealthCare Technologies were worth $6,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. United Community Bank grew its holdings in GE HealthCare Technologies by 10.2% in the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after buying an additional 130 shares in the last quarter. Thoma Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after acquiring an additional 136 shares during the last quarter. Klingman & Associates LLC boosted its position in shares of GE HealthCare Technologies by 4.0% during the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after acquiring an additional 139 shares during the last quarter. Colonial Trust Advisors boosted its position in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after acquiring an additional 139 shares during the last quarter. Finally, Norinchukin Bank The grew its holdings in shares of GE HealthCare Technologies by 0.4% in the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after purchasing an additional 149 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on GEHC. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Wells Fargo & Company dropped their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a report on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $80.67.

GE HealthCare Technologies Trading Down 0.6%

Shares of GEHC stock opened at $61.89 on Thursday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The firm has a market cap of $28.15 billion, a PE ratio of 14.81, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company has a 50-day moving average of $70.26 and a two-hundred day moving average of $76.95. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same period last year, the firm posted $1.01 earnings per share. GE HealthCare Technologies’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Buying and Selling

In other news, Director Watkin Phoebe L. Yang acquired 1,000 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was acquired at an average cost of $63.01 per share, with a total value of $63,010.00. Following the completion of the purchase, the director owned 13,702 shares of the company’s stock, valued at $863,363.02. This represents a 7.87% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Peter J. Arduini acquired 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought 11,847 shares of company stock valued at $719,555 over the last quarter. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.